Rowland & CO Investment Counsel Amgen Inc Transaction History

Rowland & CO Investment Counsel

$455 Million
Q2 2024

A detailed history of Rowland & CO Investment Counsel transactions in Amgen Inc stock. As of the latest transaction made, Rowland & CO Investment Counsel holds 18,405 shares of AMGN stock, worth $5.88 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares

18,405

Previous 18,715 1.66%

Holding current value

$5.88 Million

Previous $5.32 Million 8.06%

% of portfolio

1.26%

Previous 1.13%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$262.75 - $319.31 $81,452 - $98,986	-310 Reduced 1.66%	18,405 $5.75 Million
Q1 2024 Apr 08, 2024	SELL	$268.87 - $324.56 $20,434 - $24,666	-76 Reduced 0.4%	18,715 $5.32 Million
Q4 2023 Jan 03, 2024	SELL	$255.7 - $288.46 $7,671 - $8,653	-30 Reduced 0.16%	18,791 $5.41 Million
Q3 2023 Oct 26, 2023	SELL	$218.65 - $271.46 $19,459 - $24,159	-89 Reduced 0.47%	18,821 $5.06 Million
Q2 2023 Aug 04, 2023	SELL	$214.27 - $253.37 $13,927 - $16,469	-65 Reduced 0.34%	18,910 $4.2 Million
Q1 2023 Apr 25, 2023	SELL	$225.79 - $275.2 $69,317 - $84,486	-307 Reduced 1.59%	18,975 $4.59 Million
Q4 2022 Jan 04, 2023	BUY	$229.03 - $291.01 $81,305 - $103,308	355 Added 1.88%	19,282 $0
Q3 2022 Oct 06, 2022	BUY	$224.46 - $253.15 $1,122 - $1,265	5 Added 0.03%	18,927 $4.27 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $6,921 - $7,702	-30 Reduced 0.16%	18,922 $4.6 Million
Q1 2022 Apr 26, 2022	SELL	$219.27 - $242.57 $123,229 - $136,324	-562 Reduced 2.88%	18,952 $4.58 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $11,733 - $13,428	59 Added 0.3%	19,514 $4.39 Million
Q3 2021 Nov 08, 2021	BUY	$212.27 - $248.7 $23,349 - $27,357	110 Added 0.57%	19,455 $4.14 Million
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $25,519 - $29,739	-115 Reduced 0.59%	19,345 $4.81 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $41,328 - $49,214	191 Added 0.99%	19,460 $4.47 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $43,644 - $48,536	-186 Reduced 0.96%	19,269 $4.9 Million
Q2 2020 Aug 10, 2020	BUY	$197.81 - $242.74 $36,792 - $45,149	186 Added 0.97%	19,455 $4.59 Million
Q1 2020 May 11, 2020	SELL	$182.24 - $241.7 $121,007 - $160,488	-664 Reduced 3.33%	19,269 $3.91 Million
Q4 2019 Jan 28, 2020	BUY	$189.21 - $243.2 $167,450 - $215,232	885 Added 4.65%	19,933 $4.81 Million
Q3 2019 Oct 02, 2019	BUY	$174.11 - $208.62 $80,438 - $96,382	462 Added 2.49%	19,048 $3.69 Million
Q2 2019 Jul 09, 2019	BUY	$166.7 - $195.41 $29,172 - $34,196	175 Added 0.95%	18,586 $0
Q1 2019 Apr 10, 2019	BUY	$180.87 - $203.88 $17,544 - $19,776	97 Added 0.53%	18,411 $0
Q4 2018 Feb 12, 2019	SELL	$178.4 - $208.25 $41,032 - $47,897	-230 Reduced 1.24%	18,314 $3.57 Million
Q3 2018 Oct 22, 2018	SELL	$185.29 - $208.89 $31,128 - $35,093	-168 Reduced 0.9%	18,544 $0
Q2 2018 Jul 11, 2018	SELL	$166.05 - $186.51 $73,892 - $82,996	-445 Reduced 2.32%	18,712 $0
Q1 2018 Apr 17, 2018	SELL	$169.43 - $198.0 $41,510 - $48,510	-245 Reduced 1.26%	19,157 $0
Q4 2017 Jan 11, 2018	BUY	$168.79 - $188.59 $50,637 - $56,577	300 Added 1.57%	19,402 $0
Q3 2017 Oct 11, 2017	SELL	$167.29 - $191.0 $87,325 - $99,702	-522 Reduced 2.66%	19,102 $0
Q3 2017 Oct 11, 2017	BUY	$167.29 - $191.0 $3.28 Million - $3.75 Million	19,624	19,624 $0

Others Institutions Holding AMGN

# of Institutions

3,057

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.3M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rowland & CO Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Rowland & CO Investment Counsel with notifications on news.

Account

Rowland & CO Investment Counsel Amgen Inc Transaction History